EpiCypher Inc.

EpiCypher Inc. EpiCypher is a bioscience company developing unique reagents and services for chromatin biology and epigenetics research.

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our innovation is a direct result of the scientific power associated with EpiCypher. Our renowned chr

omatin researchers possess expertise and unique insight into epigenetics that benefit our customers in ways other companies cannot. Arising from an abundance of demand for high quality products from the laboratories of Mark Bedford, Brian Strahl, and Or Gozani EpiCypher was founded on January 18, 2012 as a spin-out from University of North Carolina at Chapel Hill. Starting with the groundbreaking and proprietary histone peptide array platform, EpiGold™, EpiCypher has developed a wide portfolio of best in class products. EpiCypher's mission is to develop products to enable researchers to complete experiments that are not otherwise possible.

Join EpiCypher, DNAnexus, and The Scientist on a live webinar TODAY at 1PM EDT! Explore how integrated experimental and ...
08/26/2026

Join EpiCypher, DNAnexus, and The Scientist on a live webinar TODAY at 1PM EDT!

Explore how integrated experimental and computational approaches are advancing epigenetics research and uncovering new mechanisms of disease.

Aaron Viny, MD, of Columbia University will share research showing how mutations in STAG2 alter chromatin accessibility and redirect the transcription factor GATA1, disrupting normal blood cell development in myelodysplastic syndromes.

EpiCypher’s Matthew Marunde, PhD, will also discuss how automated CUT&RUN enables high-throughput chromatin profiling and how CUTANA™ Cloud leverages DNAnexus's scalable cloud infrastructure to simplify epigenomic data analysis and interpretation.

📅 TODAY. August 26th
⏰ 1:00–2:00 PM ET
Register here: https://www.the-scientist.com/decoding-cell-fate-in-blood-cancer-through-epigenomics-74722

📣 New webinar: Decoding Cell Fate in Blood Cancer Through EpigenomicsJoin EpiCypher, DNAnexus and The Scientist on Augus...
08/21/2026

📣 New webinar: Decoding Cell Fate in Blood Cancer Through Epigenomics

Join EpiCypher, DNAnexus and The Scientist on August 26th to explore how integrated experimental and computational approaches are advancing epigenetics research and uncovering new mechanisms of disease.

Aaron Viny, MD, of Columbia University will share research showing how mutations in STAG2 alter chromatin accessibility and redirect the transcription factor GATA1, disrupting normal blood cell development in myelodysplastic syndromes.

EpiCypher’s Matthew Marunde, PhD, will also discuss how automated CUT&RUN enables high-throughput chromatin profiling and how CUTANA™ Cloud leverages DNAnexus's scalable cloud infrastructure to simplify epigenomic data analysis and interpretation.

📅 August 26, 2026
⏰ 1:00–2:00 PM ET

Register now: https://ow.ly/Q73850ZyJhg

🧬 Better chromatin mapping starts before the assay begins.Sample preparation can have a major impact on the quality and ...
08/19/2026

🧬 Better chromatin mapping starts before the assay begins.

Sample preparation can have a major impact on the quality and consistency of CUT&RUN and CUT&Tag data. In our upcoming webinar with Miltenyi Biotec, we’ll share practical strategies for preparing high-quality nuclei from fresh frozen tissue and setting your experiments up for success.

You’ll hear from Carina Emery of Miltenyi Biotec and EpiCypher’s Morgan Oatley on topics including:
🔬 Tissue dissociation and nuclei extraction
🧹 Sample cleanup
🔢 Accurate nuclei counting

📅 September 2, 2026
⏰ 1:00 PM EDT

Ready to strengthen your sample prep strategy and set your chromatin mapping experiments up for success?

👉 Reserve your spot: https://app.livestorm.co/epicypher/optimizing-sample-preparation-for-epigenetic-assays

📣 Upcoming Webinar: Optimizing Sample Preparation for Chromatin Mapping AssaysJoin EpiCypher and Miltenyi Biotec on Sept...
08/12/2026

📣 Upcoming Webinar: Optimizing Sample Preparation for Chromatin Mapping Assays

Join EpiCypher and Miltenyi Biotec on September 2nd for a webinar on optimizing sample preparation for chromatin mapping workflows, including CUT&RUN and CUT&Tag.

📅 September 2, 2026
⏰ 1:00 PM EDT
💻 Live webinar

Carina Emery, Lead Product Manager for Sample Preparation at Miltenyi, will cover strategies for reliable tissue dissociation, nuclei extraction, cell isolation, and sample cleanup to help maximize sample quality for downstream epigenomic assays.

Then, EpiCypher Product Manager, Morgan Oatley, will share practical guidance for optimizing fresh frozen tissue samples for CUT&RUN/Tag workflows, including:

🔬 Manual and automated nuclei dissociation strategies
🧹 Cleanup approaches for generating high-quality, intact nuclei
🔢 Nuclei counting methods for accurate reaction inputs

Ready to strengthen your sample prep strategy and set your chromatin mapping experiments up for success?

👉 Register now: https://app.livestorm.co/epicypher/optimizing-sample-preparation-for-epigenetic-assays

We are giving a talk at FASEB Biological Acetylation Conference in Porto, Portugal this week!  Michael-Christopher Keogh...
08/04/2026

We are giving a talk at FASEB Biological Acetylation Conference in Porto, Portugal this week!

Michael-Christopher Keogh, PhD, EpiCypher’s Chief Scientific Officer, will present “Mapping the Histone PTM Landscape of the Mouse Immune System with Low-Input Automated CUT&RUN.”

Join us on August 6th at Session 9, 8:55am-9:20am.

View the conference agenda: https://events.faseb.org/event/biological-acetylation/agenda

🧫What enables cancer cells to escape targeted therapy?🧬RNA-seq and ATAC-seq can reveal transcriptional rewiring during d...
07/29/2026

🧫What enables cancer cells to escape targeted therapy?

🧬RNA-seq and ATAC-seq can reveal transcriptional rewiring during drug resistance, but identifying the transcription factors driving those changes requires direct chromatin mapping of transcription factor binding.

📝Our latest blog explores how mapping transcription factor occupancy with CUTANA™ CUT&RUN helped researchers uncover a MAPK-dependent mechanism of resistance to TEAD inhibition and identify a potential combination strategy to restore drug sensitivity in cancer cells.

🔗 Read the blog: https://ow.ly/hEcT50ZtrEj

Did you miss us at AACR Drug Discovery and Development (AACR D3) last week? Download our posters to see the exciting sci...
07/27/2026

Did you miss us at AACR Drug Discovery and Development (AACR D3) last week? Download our posters to see the exciting science presented by our , Morgan Oatley and Keith Maier!

1️⃣Fiber-seq connects genetic variation to epigenomic function on single DNA molecules
🔗https://ow.ly/ZFZc50ZstVm

2️⃣Chromatin profiling from formalin-fixed paraffin-embedded (FFPE) samples for biomarker discovery
🔗https://ow.ly/tSZV50ZstVh

⏰ Time is running out to save on CUTANA™ CUT&Tag Kits! Take advantage of EpiCypher’s summer promotion and receive 15% of...
07/24/2026

⏰ Time is running out to save on CUTANA™ CUT&Tag Kits!

Take advantage of EpiCypher’s summer promotion and receive 15% off CUTANA™ CUT&Tag Kits with promo code CTK15 through August 31, 2026.

CUTANA™ CUT&Tag delivers a faster, simpler alternative to traditional chromatin mapping approaches, with low cell input requirements, strong signal-to-noise, and workflows designed to help researchers generate high-quality epigenomic data with confidence.

✅ 24- and 48-reaction kit sizes available
✅ Optimized workflows for histone PTMs and chromatin-associated proteins
✅ For researchers looking to scale chromatin profiling without compromising data quality

Shop now: https://www.epicypher.com/product/cutana-cuttag-kit/

*Available to customers in the U.S. and through participating distributors. Additional terms may apply.

Are you attending AACR Drug Discovery and Development (AACR D3)?  Join   Morgan Oatley, PhD, during Poster Session B ton...
07/23/2026

Are you attending AACR Drug Discovery and Development (AACR D3)?

Join Morgan Oatley, PhD, during Poster Session B tonight (7/23) from 6:15–8:45 p.m. to learn how chromatin profiling can unlock meaningful gene regulatory insights from valuable FFPE tissue collections. 🧬 Find her at Poster B012!

Check out her poster here: https://ow.ly/hI6v50Zs2az

Address

6 Davis Drive
Durham, NC
27709

Alerts

Be the first to know and let us send you an email when EpiCypher Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EpiCypher Inc.:

Shortcuts

Share